“…[23] (6S,7S,5R,8S,13R,14S,17S)-17-tert-Butoxy-13-methyl-spiro ( 3,4,5,6,7,8,11,12,13,14,15,16,17- ; the X-ray crystal structure analysis of trans-22 has previously been published. [23] (3 aR,3 bS,9 aS,10 S,12 aS,12 bR,12 cS)-10-tert-Butoxy-2,9 a-dimethyl- 3 b,6,7,8,9,9 a,10,11,12,12 (5R,8S,13S,14S,17S)-Spiro(1',3'-dioxolane-[2',3]-17-tert-butoxy-6-chloro-13-methyl-2, 3,4,5,6,7,8,11,12,13,14,15,16,17- 24.75 (À, CH 2 ), 25.13 (À, CH 2 ), 25.59 (À, CH 2 ), 25.74 (À, CH 2 ), 25.94 (À, CH 2 ), 26.80 (À, CH 2 ), 28.67 (+ , 3C, CA C H T U N G T R E N N U N G (CH 3 ) 3 ), 29.24 (À, CH 2 ), 31.11 (À, CH 2 ), 31.21 (À, CH 2 ), 34.45 (+ , CH), 35.13 (À, CH 2 ), 35.48 (À, CH 2 ), 35.66 (À, CH 2 ), 37.40 (À, CH 2 ), 40.79 (À, CH 2 ), 41.42 (À, CH 2 ), 41.56 (À, CH 2 ), 41.82 (À, CH 2 ), 42.70 (À, C quat ), 43.41 (À, C quat (5R,6S,7S,8S,13S,14S,17S)-17-tert-Butoxy-13-methyl-3-oxo-2, 3,4,5,6,7,8,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-6,7-dicarbonitrile (trans-32): p-Toluenesulfonic acid (80.0 mg, 0.402 mmol) was added to a solution of the steroid analogue trans-22 (330 mg, 777 mmol) in acetone (15.0 mL) and water (0.050 mL). The resulting solution was stirred at 23 8C for 24 h. After this time, the reaction mixture was concentrated in vacuo, and the residue was taken up in diethyl ether (55 mL).…”